Infant Massage for Lymphedema and Comfort in Preterm Newborns
The Effectiveness of Infant Massage in Reducing Immobilization-Related Lymphedema Symptoms and Increasing Comfort in Preterm Newborns
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
This randomized controlled trial investigates the effectiveness of infant massage in reducing symptoms of immobilization-related lymphedema and improving comfort in preterm newborns hospitalized in the Neonatal Intensive Care Unit (NICU). Preterm infants frequently develop lymphedema due to their immature circulatory systems and prolonged lack of movement. The study compares two groups of infants: one receiving standard care and another receiving a daily 15-minute massage therapy session for 14 consecutive days in addition to standard care. Researchers will evaluate the impact of the massage by measuring the circumference of the infants' wrists, elbows, ankles, and knees to assess fluid reduction. Additionally, the infants' comfort levels will be assessed using the Premature Infant Comfort Scale (PICS). The goal is to determine if massage can serve as a safe, non-invasive method to manage lymphedema and reduce distress in this vulnerable population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 4, 2026
CompletedFirst Posted
Study publicly available on registry
February 18, 2026
CompletedStudy Start
First participant enrolled
April 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 1, 2027
February 18, 2026
February 1, 2026
3 months
February 4, 2026
February 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Extremity Circumference
Circumference measurements of the upper and lower extremities (specifically the wrist, elbow, ankle, and knee) will be taken using a non-elastic tape measure. Measurements are recorded in centimeters to assess the reduction of fluid accumulation. A decrease in circumference indicates improvement in lymphedema symptoms.
Baseline (Day 0), Day 7, and Day 14
Change in Pitting Edema Grade
Pitting edema severity is assessed by applying gentle pressure to the edematous area for 5 seconds and observing the depth and duration of the indentation (pitting). It is graded on a standard clinical scale (e.g., +1 to +4), where higher scores indicate more severe edema and lower scores indicate improvement.
Baseline (Day 0), Day 7, and Day 14
Secondary Outcomes (4)
Change in Comfort Level (Premature Infant Comfort Scale)
Baseline (Day 0), Day 7, and Day 14 (Assessed before and after the intervention)
Change in Heart Rate
Baseline (Day 0), Day 7, and Day 14 (Measured before, during, and after intervention)
Change in Oxygen Saturation
Baseline (Day 0), Day 7, and Day 14 (Measured before, during, and after intervention)
Change in Body Temperature
Baseline (Day 0), Day 7, and Day 14 (Measured before, during, and after intervention)
Study Arms (2)
Infant Massage Group
EXPERIMENTALThe massage application consists of gentle tactile stimulation targeting the extremities and lymphatic drainage pathways. The therapy is performed for 15 minutes once daily for 14 days by a trained researcher/nurse. The technique is adapted for preterm physiology to ensure safety and comfort.
Control Group
NO INTERVENTIONRoutine clinical management provided to preterm infants in the NICU, including standard medical treatment, feeding, positioning, and hygiene care according to the unit's protocols.
Interventions
The intervention involves a standardized infant massage therapy protocol applied by a trained researcher. The massage consists of gentle tactile stimulation targeting the upper and lower extremities to facilitate lymphatic drainage. The sessions are conducted for 15 minutes, once daily, for a period of 14 consecutive days. This intervention is provided in addition to standard NICU care.
Eligibility Criteria
You may qualify if:
- To ensure a homogenous and clinically stable sample, infants meeting the following criteria will be recruited:
- Clinical diagnosis of lymphedema.
- Hemodynamic and clinical stability.
- No current or recent (within 24 hours) administration of analgesic or sedative medications that could mask comfort assessments.
- Intact skin integrity with no contraindications for topical massage.
- Absence of congenital heart disease or neurological disorders (antenatal or postnatal diagnosis).
- No immediate requirement for endotracheal aspiration.
- Requirement for only non-invasive respiratory support (e.g., nCPAP).
- Provision of written informed consent by the legal guardians (parents).
You may not qualify if:
- Infants will be excluded if they present with:
- Major congenital anomalies.
- Severe respiratory, cardiac, or neurological instability during the study period.
- Any acute medical contraindication identified by the attending neonatologist.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ayşe Gürol, PhD
Erzurum Technical University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
February 4, 2026
First Posted
February 18, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
April 1, 2027
Last Updated
February 18, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to privacy laws and ethical restrictions.